Edwards Lifesciences
$85.019876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$85.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.91 (+2.30%) As of 5:23 PM UTC today
Why Robinhood?
You can buy or sell EW and other stocks, options, and ETFs commission-free!
About EW
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA. The listed name for EW is Edwards Lifesciences Corp.
CEO
Michael A. Mussallem
Employees
14,900
Headquarters
Irvine, California
Founded
1958
Market Cap
53.87B
Price-Earnings Ratio
63.78
Dividend Yield
—
Average Volume
3.02M
High Today
$85.31
Low Today
$84.05
Open Price
$84.07
Volume
995.50K
52 Week High
$92.08
52 Week Low
$51.51
EW News
Analyst Ratings
52%
of 25 ratings
Buy
52%
Hold
40%
Sell
8%
EW Earnings
$0.00
$0.50
$1.01
$1.51
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 22, After Hours